Development of therapeutic medical countermeasures for biodefense and emerging infectious disease

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201300016C
Awardee
Awarding agency
Obligated
$7,063,409

Award facts

Opportunity
Contract value 100% obligated
$7,063,409.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 28 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
San Jose, CA 95138, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 · To DE-obligate remaining funds and close the contract. -$46,620
Change Order 6 · Title: development of therapeutic medical countermeasures for biodefense and emerging infectious disease $383,466
Other Administrative Action 5 · The purpose of this modification is to: (1) extend the completion date for option 3 period from november 12, 2015 to june 30, 2016 reflected in article f.1 at… $0
Other Administrative Action 4 · The purpose of this modification is to incorporate paragraph c. To article c.2. Reporting requirements, for reporting of financial conflict of interest (fcoi). $0
Other Administrative Action 3 · The purpose of this modification is to: (1) extend the completion date for the base period, option 1 period, and option 2 period to june 30, 2016 reflected in… $0
Exercise an Option 2 · The purpose of this modification is to (1) exercise option 3 in the amount of $620,545; (2) change the period of performance; and (3) update the contract… $620,545
Exercise an Option 1 · The purpose of this modification is to exercise options 1 & 2 in the amounts of $700,798 and $620,545. $1,321,343
Original award $4,784,675

Quick answers

Who was awarded contract HHSN272201300016C?

HHSN272201300016C was awarded to Aridis Pharmaceuticals, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 12, 2013.

How much is contract HHSN272201300016C worth?

The government has obligated $7,063,409 on HHSN272201300016C.

Was contract HHSN272201300016C competed?

The extent of competition for HHSN272201300016C was full and open competition. The government received 28 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login